Profile data is unavailable for this security.
About the company
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.
- Revenue in AUD (TTM)16.23m
- Net income in AUD-40.56m
- Incorporated2020
- Employees87.00
- LocationAVITA Medical Inc28159 Avenue Stanford, Suite 220VALENCIA 91355United StatesUSA
- Phone+1 (661) 367-9170
- Websitehttps://www.avitamedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percheron Therapeutics Ltd | 624.51k | -10.85m | 72.12m | 8.00 | -- | 4.38 | -- | 115.49 | -0.0157 | -0.0157 | 0.0009 | 0.0182 | 0.0328 | -- | 0.3224 | -- | -56.94 | -72.09 | -66.58 | -81.73 | -- | -- | -1,737.37 | -6,558.90 | -- | -- | 0.001 | -- | 1,026.16 | 72.03 | -95.81 | -- | -- | -- |
Neurotech International Ltd | 1.28m | -4.98m | 75.29m | -- | -- | 13.76 | -- | 58.94 | -0.0058 | -0.0058 | 0.0015 | 0.0054 | 0.1826 | -0.1149 | 5.67 | -- | -71.23 | -197.33 | -74.66 | -255.24 | 100.07 | 79.57 | -390.03 | -1,043.88 | 18.35 | -- | 0.00 | -- | 106.22 | 83.24 | -131.75 | -- | -- | -- |
Paradigm Biopharmaceuticals Ltd | 8.67m | -69.00m | 97.94m | -- | -- | 2.91 | -- | 11.30 | -0.2296 | -0.2296 | 0.0288 | 0.0962 | 0.1298 | -- | 2.25 | -- | -103.34 | -40.96 | -127.58 | -44.13 | 99.87 | -- | -796.30 | -466.85 | -- | -348.76 | 0.0085 | -- | 7.58 | 25.42 | -32.26 | -- | -- | -- |
Argenica Therapeutics Ltd | 92.21k | -4.67m | 101.43m | -- | -- | 12.33 | -- | 1,100.04 | -0.0511 | -0.0511 | 0.001 | 0.0665 | 0.0109 | -- | 0.6384 | -- | -55.31 | -- | -69.00 | -- | -- | -- | -5,067.62 | -- | -- | -6,663.20 | 0.00 | -- | 2,340.00 | -- | -17.71 | -- | -- | -- |
Proteomics International LaboratoriesLtd | 1.44m | -5.90m | 115.19m | -- | -- | 20.12 | -- | 79.72 | -0.0518 | -0.0518 | 0.0129 | 0.0437 | 0.1817 | -- | 11.13 | -- | -75.75 | -57.79 | -87.11 | -67.57 | -- | -- | -416.78 | -229.69 | -- | -283.47 | 0.0088 | -- | -14.64 | 4.12 | -24.20 | -- | 89.02 | -- |
Actinogen Medical Ltd | 337.51k | -14.87m | 160.98m | -- | -- | 11.72 | -- | 476.97 | -0.0073 | -0.0073 | 0.0002 | 0.0051 | 0.0211 | -- | 0.7341 | -- | -92.99 | -45.55 | -105.88 | -48.24 | -- | -- | -4,405.86 | -5,369.76 | -- | -294.93 | 0.0037 | -- | 792.74 | 31.88 | -13.21 | -- | 166.95 | -- |
Arovella Therapeutics Ltd | 139.02k | -10.23m | 162.84m | 14.00 | -- | 45.00 | -- | 1,171.32 | -0.0127 | -0.0127 | 0.0002 | 0.0034 | 0.0249 | -- | 15.15 | -- | -182.82 | -77.12 | -276.07 | -93.26 | 83.56 | 63.41 | -7,357.19 | -1,471.57 | -- | -- | 0.00 | -- | 45.47 | 0.3491 | -18.11 | -- | -68.72 | -- |
Cogstate Ltd | 62.35m | 8.28m | 187.86m | 61.00 | 24.82 | 3.31 | 15.13 | 3.01 | 0.0443 | 0.0443 | 0.3378 | 0.3326 | 0.7757 | -- | 5.58 | -- | 10.30 | 6.01 | 13.84 | 9.22 | 54.69 | 51.50 | 13.28 | 7.26 | -- | -- | 0.0135 | 0.00 | -8.62 | 7.25 | -52.56 | -- | -5.06 | -- |
Dimerix Ltd | 181.28k | -10.87m | 288.85m | 0.00 | -- | 130.32 | -- | 1,593.41 | -0.0294 | -0.0294 | 0.0005 | 0.004 | 0.0169 | -- | 0.7586 | -- | -101.36 | -70.77 | -128.88 | -110.81 | -- | -- | -5,994.52 | -61,882.73 | -- | -- | 0.4541 | -- | 1,452.32 | 12.76 | -31.57 | -- | -8.26 | -- |
Race Oncology Ltd | 885.59k | -11.17m | 297.18m | -- | -- | 13.96 | -- | 335.57 | -0.069 | -0.069 | 0.0055 | 0.125 | 0.0336 | -- | 0.326 | -- | -42.44 | -43.50 | -43.67 | -45.25 | -- | -- | -1,261.86 | -5,058.82 | -- | -- | 0.00 | -- | 997.63 | 93.78 | 11.41 | -- | -- | -- |
AVITA Medical Inc | 16.23m | -40.56m | 299.11m | 87.00 | -- | 205.13 | -- | 18.43 | -0.0288 | -0.0288 | 0.0114 | 0.0117 | 0.1882 | 2.86 | 5.89 | 186,506.20 | -47.05 | -121.83 | -51.04 | -152.54 | 78.72 | 73.46 | -249.98 | -633.80 | 15.22 | -197.63 | 0.0301 | -- | 543.96 | 24.92 | -112.85 | -- | 88.43 | -- |
Imugene Ltd | 0.00 | -89.24m | 373.31m | 0.00 | -- | 1.88 | -- | -- | -0.0132 | -0.0132 | 0.00 | 0.0272 | 0.00 | -- | -- | -- | -40.29 | -26.64 | -43.53 | -28.00 | -- | -- | -- | -- | -- | -- | 0.021 | -- | -- | -- | -0.1207 | -- | -- | -- |
Immutep Ltd | 256.62k | -40.50m | 421.26m | 19.00 | -- | 3.01 | -- | 1,641.56 | -0.039 | -0.039 | 0.0002 | 0.0964 | 0.0025 | -- | 2.48 | -- | -38.61 | -36.31 | -41.57 | -39.21 | -- | -- | -15,782.59 | -919.13 | -- | -- | 0.0138 | -- | -24.64 | -51.34 | -23.86 | -- | 47.40 | -- |
Holder | Shares | % Held |
---|---|---|
Sandhurst Trustees Ltd.as of 31 Jan 2024 | 278.70k | 0.22% |